LiGHT 2026

AWAK Technologies Earns FDA Breakthrough Status for AI-Driven Kidney Disease Predictor

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

WebMD Ignite Ruby Transforms Healthcare Marketing...

WebMD Ignite has announced the launch of WebMD Ignite...

Mayo Clinic Study Validates AI Tool...

Researchers at Mayo Clinic have found that an artificial...

MHRA Outlines New Agenda for AI...

The United Kingdomโ€™s Medicines and Healthcare products Regulatory Agency...

AWAK Technologies, a forefront medical technology company specializing in wearable dialysis products and solutions for chronic kidney disease (CKD) management, announced the FDA Breakthrough Device designation for its kidney disease progression prediction (KDPP) Artificial Intelligence (AI) model. The collaboration with Ever Fortune.AI (EFAI), a spin-off from China Medical University Hospital (CMUH) in Taiwan, led to the development of this innovative AI solution.

The Breakthrough Device designation from the FDA is a recognition of the potential benefits this AI model brings to CKD patient care. It signifies a significant step in AWAK’s commitment to advancing patient care and medical innovation, expediting the product validation process.

The CMUH iHi (ignite Hyper-intelligence) platform played a crucial role in developing advanced AI models that provide clinicians with sophisticated tools for CKD management, facilitating effective risk stratification and optimized resource allocation. This development represents a notable advancement in proactive, intelligent kidney care and healthcare technology.

To address global needs in kidney disease management, AWAK has collaborated with Singapore General Hospital (SGH). Together, they aim to develop new AI models and assess the existing KDPP model using SGH’s de-identified CKD patient database, extending the impact of this innovative approach.

Never miss a healthcare headline

Healthcare moves fast โ€“ stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

Mayo Clinic Study Validates AI Tool DEXI for Skin Lesion Assessment

Researchers at Mayo Clinic have found that an artificial...

MHRA Outlines New Agenda for AI Medical Devices at AdvaMed

The United Kingdomโ€™s Medicines and Healthcare products Regulatory Agency...

UK Confirms Indefinite Use of CE Marked Medical Devices

The United Kingdom government has officially confirmed the indefinite...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป